Posted in | News | Discoveries

Canada Fluorspar Provides Update on 2012 Trenching Operations on Director Vein

Canada Fluorspar, a specialty mineral resource company, has provided an update of its reconnaissance operations on the Director Vein, which is situated on the firm’s development properties in St. Lawrence, Newfoundland.

For almost three months, the company has performed surface trenching operations at the Director Vein, and so far has discovered fluorspar mineralization at six places. At present, the trenches lie across a region extending 850 m towards the south of the Director Vein’s old mine workings, and signify surface mineralization in thickness ranging from 3.4 m to 23 m. Based on these results, the trenching activity will be continued till next month. Additionally, a drilling campaign on the Director Vein’s southern extension is anticipated to begin in Q2 of 2012. Assay results of the trench samples will be released shortly.

Under the present reconnaissance campaign, Canada Fluorspar is planning to conclude at least two more trenches on the Director Vein. This decision also pertains to the positive findings from the sixth and seventh trenches.

Mining at trench #6 revealed a 21.5 m broad fault structure that included a brecciated granite zone measuring 12.5 m wide with fluorite traces on fracture surfaces; and a 9 m broad section of fault gouge comprising quartz, fluorite, and brecciated granite.

Trench #7 also revealed a 12.5 m wide structure comprising a brecciated granite section measuring 12.5 m wide with purple fluorite traces along fracture surfaces; and a 6 m of brecciated granite with fluorite traces and 4.5 m of fault gouge.

Quartz, fluorite and brecciated granite are included in the gouge material, which is similar to the gouge that remains open in the adjoining trench #5 that is 100 m to the north. The company has mapped the trenches and collected samples from the mineralized interval for analysis.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Canada Fluorspar Inc.. (2019, February 18). Canada Fluorspar Provides Update on 2012 Trenching Operations on Director Vein. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=6193.

  • MLA

    Canada Fluorspar Inc.. "Canada Fluorspar Provides Update on 2012 Trenching Operations on Director Vein". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=6193>.

  • Chicago

    Canada Fluorspar Inc.. "Canada Fluorspar Provides Update on 2012 Trenching Operations on Director Vein". AZoMining. https://www.azomining.com/News.aspx?newsID=6193. (accessed November 21, 2024).

  • Harvard

    Canada Fluorspar Inc.. 2019. Canada Fluorspar Provides Update on 2012 Trenching Operations on Director Vein. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=6193.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.